Cogent Biosciences, Inc. (COGT) /
The debt of Cogent Biosciences, Inc. over the past 9 years
Chart Cogent Biosciences, Inc.: liquid cash, total debt, net cash, fiscal 2017–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, Cogent Biosciences, Inc. had liquid cash of $900.76M and total debt of $222.9M: net cash of $677.87M. It had more liquid cash than debt at all 9 year-ends shown. Total debt was highest at the end of fiscal 2025 ($222.9M) and lowest at the end of fiscal 2017 ($0).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $900.76M* | $222.9M | $677.87M |
| 2024ended Dec 31, 2024 | $287.08M* | $0 | $287.08M |
| 2023ended Dec 31, 2023 | $265.71M* | $0 | $265.71M |
| 2022ended Dec 31, 2022 | $259.28M* | $0 | $259.28M |
| 2021ended Dec 31, 2021 | $219.68M* | $0 | $219.68M |
| 2020ended Dec 31, 2020 | $242.19M | $0 | $242.19M |
| 2019ended Dec 31, 2019 | $37.42M | $0 | $37.42M |
| 2018ended Dec 31, 2018 | $78.59M* | $0 | $78.59M |
| 2017ended Dec 31, 2017 | $40.96M* | $0 | $40.96M |
Fiscal years as Cogent Biosciences, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Cogent Biosciences, Inc.
- The revenue of Cogent Biosciences, Inc.
- The profitability of Cogent Biosciences, Inc.
- The cash flow of Cogent Biosciences, Inc.
- All of Cogent Biosciences, Inc.'s financials, charted
Companies of a similar size
- RITMRithm Capital Corp.
- IBPInstalled Building Products, Inc.
- AMTMAmentum Holdings, Inc.
- PSNParsons Corporation
- PECOPhillips Edison & Company, Inc.
Not investment advice. This page shows what Cogent Biosciences, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.